Form 4: UHS Director Plans Option Exercise and Share Sales

Universal Health Services Director Warren J. Nimetz filed a Form 4 detailing planned option exercise and subsequent share sales under a 10b5-1 plan.

Summary

• Universal Health Services Director Warren J. Nimetz has filed a Form 4 detailing planned transactions for November 11, 2025.
• These transactions include the exercise of 10,000 Class B Common Stock options at an exercise price of $138.80 per share.
• Following the option exercise, Nimetz plans to dispose of 6,183 shares at $224.49 for tax withholding purposes.
• Additionally, Nimetz plans to sell 3,675 shares at a weighted average price of $223.2766 and 142 shares at a weighted average price of $223.9563.
• All planned transactions are being conducted under a Rule 10b5-1(c) plan.
• After these planned transactions, Nimetz's direct beneficial ownership of Class B Common Stock will be 8,481 shares, representing no net change in beneficial ownership from the start of the reported sequence of transactions.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions involving option exercise and subsequent share sales, likely under a pre-arranged 10b5-1 plan, which is neutral for company operations and does not indicate a significant shift in company fundamentals.

Positives

• The planned exercise of options at $138.80 and subsequent sale at prices around $223-$224 indicates a significant profit for the director on these shares.
• The use of a Rule 10b5-1 plan demonstrates a pre-arranged, transparent approach to insider trading, mitigating concerns about opportunistic timing.

Negatives

• The planned sale of 10,000 shares, even if acquired through options, represents a decision by the director to reduce their direct equity exposure at the current market price, albeit offset by the option exercise.

Future Outlook

The filing details planned future transactions by a director, specifically the exercise of stock options and subsequent sale of shares, scheduled for November 11, 2025, under a Rule 10b5-1 plan.

Management Comments

• Transactions were made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

This Form 4 filing is specific to an individual director's equity transactions and does not provide broader industry context or trends for the healthcare services sector in which Universal Health Services operates.

Stakeholder Impact

• Shareholders: The transactions are pre-planned under a 10b5-1 plan, which generally reduces the signaling effect of insider sales. The exercise of options and subsequent sale of an equivalent number of shares results in no net change in the director's overall beneficial ownership from the start of the reported sequence of transactions.

Key Dates

Recommendation

The Form 4 details a director's exercise of stock options and subsequent sale of shares, likely under a pre-arranged 10b5-1 plan. This is a routine insider transaction and does not provide sufficient new information regarding the company's operational performance or future prospects to warrant a change in investment recommendation.

Keywords

Universal Health Services, UHS, Form 4, Insider Trading, Stock Options, Director Transactions, Equity Sales, Beneficial Ownership, 10b5-1 Plan